-
The emergence of chronic wasting disease, a transmissible spongiform encephalopathy in North American cervids, raises concern about potential transmission to humans, as has occurred elsewhere with bovine spongiform encephalopathy and vCJD.
-
Conference coverage: emerging infections and outbreaks, malaria, schistosomiasis, bacterial infections
-
At the 51st meeting of the American Society of Tropical Medicine and Hygiene in Denver, November 10-14, 2002, a full symposium was devoted to yellow fever.
-
Two recent publications cover common issues pertinent to travelers. There is a new way to expedite the diagnosis and treatment of myiasis, which is reviewed here. Included is also a synopsis of an illustrative article to make available to those who give advice to travelers regarding health care abroad.
-
Although Japanese encephalitis rarely occurs in travelers, certain groups and subsets of individuals have a risk of infection that can reach 1 in 5000 travelers per week. It is crucial to recognize those with increased risk, and to seriously consider immunizing them in order to prevent the potentially devastating sequelae of Japanese encephalitis.
-
This invited article reviewing schistosomiasis in travelers describes the pertinent features of this disease as it presents in the nonimmune tourist.
-
Careful evaluation of epidemiologic data from recent African outbreaks of meningococcal disease suggests that significant risks now extend beyond the sub-Saharan belt through the Rift Valley and Great Lakes regions into Mozambique, then into Namibia and Angola.
-
Review of Efficacy of Ginkgo; Celebrex OK for Asthma Patients; Losartan Not Superior to Captopril; Alfa-Interferon Could Help Fight West Nile; FDA Actions
-
In October of 2005, the first reports of 5 cases and the possible association of Guillain-Barré Syndrome (GBS) and recipients of Menactra® Meningococcal Conjugate Vaccine (MCV4) were reported.
-
Drug Labels A Prescription for Misunderstanding?; Osteonecrosis of the Jaw New Side-Effect to Bisphosphate Use; Beta-Blockers and Depression Unlinked?; FDA Actions
